What is Cartalax?
Cartalax is a synthetic short peptide belonging to the class of regulatory peptides. With high purity and stability, it is widely utilized in research investigating cartilage, connective tissue, and cellular metabolism. Cartalax is supplied strictly for laboratory use and is not intended for human consumption or therapeutic application.
Research Applications of Cartalax
-
Molecular and Structural Studies
Cartalax is a dipeptide bioregulator derived from the amino acid sequence Glu-Asp. Research focuses on its structural characteristics and role in peptide signaling. Studies explore how such short peptides can regulate gene expression, protein synthesis, and cell differentiation through selective interactions with nucleic acids and chromatin structures [1].
-
Cartilage and Connective Tissue Research
Cartalax is frequently studied in the context of connective tissue biology. Experimental models have used Cartalax to investigate peptide interactions with extracellular matrix proteins and their influence on chondrocyte activity. Such studies provide insight into how regulatory peptides may contribute to tissue-specific repair mechanisms and molecular signaling pathways in cartilage research [2].
-
Gerontology and Aging Research
Cartalax has also been investigated in the field of biogerontology. Research suggests that short regulatory peptides may contribute to maintaining genomic stability and modulating the activity of tissue-specific genes during aging. Cartalax, in particular, is studied for its role in cartilage and joint-related systems, making it a subject of interest in aging-related molecular biology [3].
-
Peptide Bioregulation and Gene Expression
As part of the larger family of cytomedins, Cartalax is used in experimental studies to evaluate the potential of short peptides to regulate transcriptional activity. This line of research aims to map peptide–DNA interactions and their downstream influence on protein synthesis, epigenetic modifications, and cell cycle regulation [4].
Reconstitution and dosing
Cartalax is typical reconstituted with Bacteriostatic water in various concentrations, usually in 10mg/ml. Cartalax is typically dosed at 2mg per day for 20 days and this protocol is followed 2-3 times per year for Lung health and support.
For our free Peptide Calculator CLICK HERE
Referenced Citations
- Khavinson VKh, Malinin VV. Peptides and Ageing: Gene Expression Regulation by Short Peptides. PubMed
- Khavinson VKh, Popovich IG, Anisimov VN. Peptide regulation of cartilage and connective tissue in experimental models. PubMed
- Khavinson VKh, et al. Short peptides and their role in aging research. PubMed
- Malinin VV, Khavinson VKh. Molecular mechanisms of peptide regulation of gene expression. PubMed
Disclaimer
ALL ARTICLES AND PRODUCT INFORMATION PROVIDED ON THIS WEBSITE ARE FOR INFORMATIONAL AND EDUCATIONAL PURPOSES ONLY.
